Lobe Sciences Ltd. (CSE:LOBE)

Canada flag Canada · Delayed Price · Currency is CAD
0.0550
-0.0050 (-8.33%)
Mar 2, 2026, 9:36 AM EST
83.33%
Market Cap 14.82M
Revenue (ttm) n/a
Net Income (ttm) -4.54M
Shares Out 269.49M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,800
Average Volume 74,358
Open 0.0550
Previous Close 0.0600
Day's Range 0.0550 - 0.0550
52-Week Range 0.0200 - 0.1100
Beta -0.25
RSI 50.48
Earnings Date Apr 27, 2026

About Lobe Sciences

Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The company was founded in 2018 and is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol LOBE
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.